Your browser is no longer supported. Please, upgrade your browser.
Settings
HSGX Histogenics Corporation daily Stock Chart
HSGX [NASD]
Histogenics Corporation
Index- P/E- EPS (ttm)-0.32 Insider Own6.00% Shs Outstand94.59M Perf Week13.72%
Market Cap18.35M Forward P/E- EPS next Y-0.03 Insider Trans-14.96% Shs Float88.51M Perf Month39.77%
Income-8.50M PEG- EPS next Q-0.01 Inst Own10.90% Short Float0.54% Perf Quarter25.40%
Sales- P/S- EPS this Y76.40% Inst Trans-8.83% Short Ratio0.05 Perf Half Y-71.46%
Book/sh-0.01 P/B- EPS next Y0.00% ROA-52.60% Target Price5.00 Perf Year-92.87%
Cash/sh0.16 P/C1.18 EPS next 5Y- ROE63.50% 52W Range0.08 - 3.05 Perf YTD119.46%
Dividend- P/FCF- EPS past 5Y38.20% ROI- 52W High-93.64% Beta3.52
Dividend %- Quick Ratio5.70 Sales past 5Y- Gross Margin- 52W Low142.50% ATR0.03
Employees49 Current Ratio5.70 Sales Q/Q- Oper. Margin- RSI (14)59.86 Volatility15.83% 14.10%
OptionableNo Debt/Eq- EPS Q/Q90.20% Profit Margin- Rel Volume0.55 Prev Close0.20
ShortableYes LT Debt/Eq- EarningsMay 09 BMO Payout- Avg Volume10.27M Price0.19
Recom3.00 SMA2030.76% SMA5041.27% SMA200-76.60% Volume5,613,040 Change-3.05%
Dec-19-16Initiated H.C. Wainwright Buy $3.50
Sep-19-16Reiterated Needham Buy $11 → $8
Nov-13-15Reiterated Needham Buy $17 → $15
Nov-13-15Reiterated Canaccord Genuity Buy $15 → $8
Jan-05-15Initiated Needham Buy $17
Jan-05-15Initiated Canaccord Genuity Buy $16.50
Apr-08-19 05:50PM  Histogenics News: Why Did HSGX Stock Soar Today? InvestorPlace +56.00%
12:48PM  Ocular Biotechs Histogenics, Ocugen Announce Stock-For-Stock Merger Benzinga
09:58AM  Histogenics to serve as shell for Pennsylvania biotech in reverse-merger American City Business Journals
09:33AM  Malvern gene therapy developer to acquire publicly traded Boston company American City Business Journals
07:00AM  Histogenics and Ocugen Enter into Definitive Merger Agreement to Create Nasdaq-Listed Clinical-Stage Company Developing Novel Ocular Gene Therapies and Biotherapeutics GlobeNewswire
Mar-25-19 05:44AM  Edited Transcript of HSGX earnings conference call or presentation 9-Nov-17 1:30pm GMT Thomson Reuters StreetEvents
Feb-20-19 08:00AM  Biotech Bounce Just Getting Started ACCESSWIRE
Feb-12-19 08:00AM  Jonathan Lieber Joins Danforth Advisors as Managing Director GlobeNewswire
Jan-31-19 08:00AM  Biotech Stocks on the Rise ACCESSWIRE +50.72%
Jan-28-19 09:30AM  Is Histogenics (HSGX) Outperforming Other Medical Stocks This Year? Zacks
Jan-23-19 08:30AM  Best Ways to Play Biotech Rally ACCESSWIRE
Jan-08-19 08:30AM  The Next Big Biotech Breakout ACCESSWIRE -10.15%
Jan-04-19 08:50AM  4 Healthcare Stocks To Watch On Friday (1/4/19) ACCESSWIRE +22.01%
Dec-21-18 04:05PM  Histogenics and FDA Conclude Discussions Regarding NeoCart® Phase 3 Clinical Trial Data and Regulatory Pathway GlobeNewswire
Nov-29-18 08:30AM  Histogenics and FDA Continue to Discuss NeoCart® Phase 3 Clinical Trial Data and Potential Regulatory Pathway GlobeNewswire -12.06%
Nov-23-18 07:50AM  New Research Coverage Highlights Intersections, PRGX Global, Ecology and Environment, Histogenics, SeaChange International, and TransAct Technologies Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Nov-12-18 06:10AM  Cell therapy biotech Vericel eyes $2B knee repair market American City Business Journals -6.71%
Nov-08-18 07:07AM  Histogenics: 3Q Earnings Snapshot Associated Press
06:30AM  Histogenics Corporation Announces Third Quarter 2018 Financial and Operating Results GlobeNewswire
Nov-01-18 04:05PM  Histogenics and FDA to Continue Discussions on NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway GlobeNewswire
Oct-25-18 04:15PM  Histogenics Corporation to Report Third Quarter 2018 Financial Results on November 8, 2018 GlobeNewswire +5.69%
Oct-24-18 08:15AM  What is Next for Histogenics, Pending FDA Meeting and Analysts Target Price ACCESSWIRE
Oct-15-18 08:00AM  Todays Research Reports on Stocks to Watch: Immune Design and Histogenics ACCESSWIRE +11.43%
Oct-10-18 04:01PM  Histogenics Corporation Announces Closing of Public Offering of Common Stock and Warrants GlobeNewswire -7.14%
Oct-05-18 08:10AM  Histogenics Corporation Announces Pricing of Public Offering of Common Stock and Warrants GlobeNewswire -39.60%
Oct-04-18 04:01PM  Histogenics Corporation Announces Proposed Public Offering of Common Stock and Warrants GlobeNewswire +51.52%
Sep-26-18 04:05PM  Histogenics to Meet With FDA to Discuss NeoCart Phase 3 Clinical Trial Data and Potential Regulatory Pathway GlobeNewswire
Sep-05-18 12:04PM  Histogenics Slips Below $1 Threshold After Knee Cartilage Candidate Fails Late-Stage Study Benzinga -72.56%
11:56AM  Histogenics to seek FDA approval for cell therapy despite failed study American City Business Journals
05:00AM  Histogenics Announces Top-Line Results From Phase 3 Clinical Trial of NeoCart® in Patients With Knee Cartilage Damage GlobeNewswire
Aug-10-18 08:40PM  Edited Transcript of HSGX earnings conference call or presentation 9-Aug-18 12:30pm GMT Thomson Reuters StreetEvents
05:08AM  Histogenics Sees Hammer Chart Pattern: Time to Buy? Zacks
Aug-09-18 06:49AM  Histogenics: 2Q Earnings Snapshot Associated Press
06:30AM  Histogenics Corporation Announces Second Quarter 2018 Financial and Operating Results GlobeNewswire
06:30AM  Histogenics Corp. to Host Earnings Call ACCESSWIRE
Jul-31-18 08:00AM  Histogenics Corporation Appoints E. Lynne Kelley, M.D., FACS As Chief Medical Officer GlobeNewswire
Jul-26-18 08:30AM  Histogenics Corporation to Report Second Quarter 2018 Financial Results on August 9, 2018 GlobeNewswire -6.87%
Jul-25-18 04:15PM  Histogenics Corporation to Present at Canaccord Genuitys 38th Annual Growth Conference GlobeNewswire
Jul-23-18 08:30AM  Histogenics Chief Operating Officer, Stephen Kennedy Appointed to Advanced Regenerative Manufacturing Institutes Technology Advisory Sub-Committee GlobeNewswire
May-31-18 08:30AM  Histogenics Corporation to Host Investor Day on June 19, 2018 GlobeNewswire
May-14-18 08:48PM  Edited Transcript of HSGX earnings conference call or presentation 10-May-18 12:30pm GMT Thomson Reuters StreetEvents
May-10-18 06:39AM  Histogenics: 1Q Earnings Snapshot Associated Press
06:30AM  Histogenics Corporation Announces First Quarter 2018 Financial and Operating Results GlobeNewswire
Apr-26-18 08:30AM  Histogenics Corporation to Report First Quarter 2018 Financial Results on May 10, 2018 GlobeNewswire
Apr-18-18 03:49PM  How Do Analysts See Histogenics Corporation (NASDAQ:HSGX) Performing Over The Next Few Years? Simply Wall St.
08:30AM  Histogenics Corporation Announces the Appointment of Susan Washer to Its Board of Directors GlobeNewswire
Mar-28-18 08:30AM  Histogenics Corporation to Present at Upcoming Investor Conferences GlobeNewswire
Mar-19-18 08:30AM  Histogenics Corporation to Present at Needham & Companys 17th Annual Healthcare Conference GlobeNewswire
Mar-16-18 08:32PM  Edited Transcript of HSGX earnings conference call or presentation 15-Mar-18 12:30pm GMT Thomson Reuters StreetEvents
Mar-15-18 06:40AM  Histogenics Corp. to Host Earnings Call ACCESSWIRE
06:35AM  Histogenics reports 4Q loss Associated Press
06:00AM  Histogenics Corporation Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2017 GlobeNewswire
Mar-02-18 08:30AM  Histogenics to Showcase NeoCart® at American Academy of Orthopedic Surgeons and Orthopedic Research Society 2018 Annual Meetings GlobeNewswire
Mar-01-18 08:30AM  Histogenics Corporation to Report 2017 Financial Results on March 15, 2018 GlobeNewswire
Feb-22-18 04:23PM  Histogenics Corporation (NASDAQ:HSGX): Is Healthcare Attractive Relative To NasdaqCM Peers? Simply Wall St.
Feb-20-18 08:30AM  Histogenics Corporation to Present at Upcoming Investor Conferences GlobeNewswire
Jan-25-18 04:05PM  Histogenics Corporation Announces Closing of Underwritten Registered Direct Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares GlobeNewswire
Jan-22-18 06:59PM  Histogenics Corporation Announces Pricing of Underwritten Registered Direct Offering of 2,340,430 Shares of Common Stock GlobeNewswire
Jan-10-18 09:52AM  What Should You Know About Histogenics Corporations (NASDAQ:HSGX) Earnings Trajectory? Simply Wall St. +7.72%
Jan-09-18 08:30AM  Histogenics Corporation Announces Receipt of $10 Million Up-front Payment for Japanese Neocart Agreement GlobeNewswire +9.82%
Dec-21-17 06:00AM  Histogenics Corporation and MEDINET Co., Ltd Enter Into Licensing Agreement for Development and Commercialization of NeoCart for the Japanese Market GlobeNewswire +18.39%
Dec-15-17 11:05AM  Interested In Histogenics Corporation (NASDAQ:HSGX)? Heres What Its Recent Track-Record Looks Like Simply Wall St.
Nov-09-17 08:52AM  Histogenics reports 3Q loss Associated Press
06:30AM  Histogenics Corporation Announces Third Quarter 2017 Financial and Operating Results GlobeNewswire
Oct-27-17 04:21PM  Histogenics Corporation (HSGX): Time For A Financial Health Check Simply Wall St.
Oct-26-17 08:30AM  Histogenics Corporation to Report Third Quarter 2017 Financial Results on November 9, 2017 GlobeNewswire
Oct-12-17 09:00AM  Histogenics Corporation Promotes Stephen Kennedy to Executive Vice President & Chief Operating Officer GlobeNewswire +8.88%
Oct-02-17 04:15PM  Histogenics Announces Publication of Additional Biomechanical Data From Human Engineered Cartilage Testing GlobeNewswire
Sep-26-17 08:30AM  Histogenics Corporation to Present at the 2017 Cell & Gene Meeting on the Mesa GlobeNewswire
Sep-13-17 04:55PM  How Should You Think About Histogenics Corporations (HSGX) Risks? Simply Wall St.
Aug-24-17 08:30AM  Histogenics Corporation to Present at Upcoming Investor Conferences GlobeNewswire
Aug-11-17 01:30PM  Edited Transcript of HSGX earnings conference call or presentation 10-Aug-17 12:30pm GMT Thomson Reuters StreetEvents
Aug-10-17 09:41PM  Histogenics reports 2Q loss Associated Press
06:30AM  Investor Network: Histogenics Corp. to Host Earnings Call ACCESSWIRE
06:30AM  Histogenics Corporation Announces Second Quarter 2017 Financial and Operating Results GlobeNewswire
Jul-27-17 08:30AM  Histogenics Corporation to Announce Second Quarter 2017 Financial Results on August 10, 2017 GlobeNewswire
Jul-26-17 08:30AM  Histogenics Corporation to Present at the 37th Annual Canaccord Genuity Growth Conference GlobeNewswire
Jul-11-17 08:30AM  Histogenics Announces Publication of Data From Collagen and Chondrocyte 3-D Bioprinting Study GlobeNewswire
Jun-27-17 04:01PM  Histogenics Completes Enrollment for Phase 3 Clinical Trial of Neocart® to Treat Knee Cartilage Damage GlobeNewswire
Jun-22-17 09:30AM  The Zacks Analyst Blog Highlights: Cambrex, Geron, Anavex Life Sciences and Histogenics Zacks
Jun-21-17 09:52AM  Fresh Capital to Be Injected into Biotech Stocks: 5 Must-Buys Zacks
Jun-05-17 08:30AM  Histogenics Corporation Announces the Appointment of Donald Haut, Ph.D. as Chief Business Officer GlobeNewswire
May-19-17 09:00AM  Edited Transcript of HSGX earnings conference call or presentation 11-May-17 12:30pm GMT Thomson Reuters StreetEvents
May-16-17 08:30AM  Histogenics Corporation to Present at Upcoming Industry Conferences GlobeNewswire
May-15-17 08:30AM  Histogenics Corporation Receives Innovation Award GlobeNewswire
May-11-17 07:30AM  Investor Network: Histogenics Corp. to Host Earnings Call Accesswire
06:44AM  Histogenics reports 1Q loss Associated Press
06:30AM  Histogenics Corporation Announces First Quarter 2017 Financial and Operating Results GlobeNewswire
May-08-17 06:30AM  Histogenics Announces Agreement With the Japan Pharmaceuticals and Medical Devices Agency Regarding Japanese Regulatory Pathway for NeoCart® GlobeNewswire
Apr-27-17 08:30AM  Histogenics Corporation To Announce First Quarter 2017 Financial Results on May 11, 2017 GlobeNewswire
Apr-24-17 04:15PM  Histogenics Corporation to Present at 5th Annual Cell & Gene Therapy Investor Day on April 27, 2017 GlobeNewswire
Mar-29-17 08:30AM  Histogenics Corporation to Present at Needham & Companys 16th Annual Healthcare Conference GlobeNewswire
Mar-27-17 04:07PM  HISTOGENICS CORP Files SEC form 8-K, Other Events
Mar-23-17 01:04PM  HISTOGENICS CORP Financials
Mar-17-17 09:35AM  Edited Transcript of HSGX earnings conference call or presentation 16-Mar-17 12:30pm GMT Thomson Reuters StreetEvents
Mar-16-17 09:37AM  Histogenics posts 4Q profit Associated Press
08:30AM  Histogenics Corp Earnings Call scheduled for 8:30 am ET today
07:32AM  HISTOGENICS CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
07:07AM  Q4 2016 Histogenics Corp Earnings Release - Before Market Open
06:30AM  Histogenics Corporation Announces Financial and Operating Results for the Fourth Quarter and Year Ended December 31, 2016 GlobeNewswire
Histogenics Corporation, a clinical-stage company, focuses on the development of restorative cell therapies in the United States. The company offers NeoCart, a tissue implant, which is in Phase III clinical trial to treat tissue injury in the field of orthopedics, specifically cartilage damage in the knee. It has an exclusive channel collaboration agreement with Intrexon Corporation for the development and commercialization of allogeneic genetically modified chondrocyte cell therapeutics for the treatment or repair of damaged articular hyaline cartilage in humans. Histogenics Corporation was founded in 2000 and is headquartered in Waltham, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
KIRK RANDAL J10% OwnerJan 15Sale0.15345,89751,8851,692,366Jan 15 05:21 PM
KIRK RANDAL J10% OwnerJan 14Sale0.16400,50764,0812,038,263Jan 15 05:21 PM
KIRK RANDAL J10% OwnerJan 11Sale0.17251,80042,8062,438,770Jan 15 05:21 PM
Gridley AdamPresident and CEOMay 16Buy2.152,0004,3007,000May 18 05:47 PM